0001140361-20-012068.txt : 20200520 0001140361-20-012068.hdr.sgml : 20200520 20200520162243 ACCESSION NUMBER: 0001140361-20-012068 CONFORMED SUBMISSION TYPE: DEFA14A PUBLIC DOCUMENT COUNT: 1 FILED AS OF DATE: 20200520 DATE AS OF CHANGE: 20200520 EFFECTIVENESS DATE: 20200520 FILER: COMPANY DATA: COMPANY CONFORMED NAME: NU SKIN ENTERPRISES, INC. CENTRAL INDEX KEY: 0001021561 STANDARD INDUSTRIAL CLASSIFICATION: WHOLESALE-DRUGS PROPRIETARIES & DRUGGISTS' SUNDRIES [5122] IRS NUMBER: 870565309 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: DEFA14A SEC ACT: 1934 Act SEC FILE NUMBER: 001-12421 FILM NUMBER: 20898393 BUSINESS ADDRESS: STREET 1: 75 WEST CENTER ST STREET 2: ATTN: GREGORY BELLISTON CITY: PROVO STATE: UT ZIP: 84601 BUSINESS PHONE: 801-345-1000 MAIL ADDRESS: STREET 1: 75 WEST CENTER ST STREET 2: ATTN: GREGORY BELLISTON CITY: PROVO STATE: UT ZIP: 84601 FORMER COMPANY: FORMER CONFORMED NAME: NU SKIN ENTERPRISES INC DATE OF NAME CHANGE: 19980909 FORMER COMPANY: FORMER CONFORMED NAME: NU SKIN ASIA PACIFIC INC DATE OF NAME CHANGE: 19960919 DEFA14A 1 formdefa14a.htm LETTER TO STOCKHOLDERS
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

SCHEDULE 14A INFORMATION

Proxy Statement Pursuant to Section 14(a) of
the Securities Exchange Act of 1934 (Amendment No.          )

Filed by the Registrant ☑
Filed by a Party other than the Registrant ☐

Check the appropriate box:
☐
Preliminary Proxy Statement
☐
Confidential, for Use of the Commission Only (as permitted by Rule 14a-6(e)(2))
☐
Definitive Proxy Statement
☑
Definitive Additional Materials
☐
Soliciting Material Pursuant to §240.14a-12

NU SKIN ENTERPRISES, INC.
(Name of Registrant as Specified In Its Charter)

 
(Name of Person(s) Filing Proxy Statement, if other than the Registrant)

Payment of Filing Fee (Check the appropriate box):
☑
No fee required.
☐
Fee computed on table below per Exchange Act Rules 14a-6(i)(1) and 0-11.
 
(1)
Title of each class of securities to which transaction applies:
 
(2)
Aggregate number of securities to which transaction applies:
 
(3)
Per unit price or other underlying value of transaction computed pursuant to Exchange Act Rule 0-11 (set forth the amount on which the filing fee is calculated and state how it was determined):
 
(4)
Proposed maximum aggregate value of transaction:
 
(5)
Total fee paid:
 
 
☐
Fee paid previously with preliminary materials.
 
 
☐
Check box if any part of the fee is offset as provided by Exchange Act Rule 0-11(a)(2) and identify the filing for which the offsetting fee was paid previously. Identify the previous filing by registration statement number, or the Form or Schedule and the date of its filing.
 
(1)
Amount Previously Paid:
 
(2)
Form, Schedule or Registration Statement No.:
 
(3)
Filing Party:
 
(4)
Date Filed:

LETTER TO STOCKHOLDERS OF NU SKIN ENTERPRISES, INC.
May 20, 2020
Dear Stockholders,
We, the Board of Directors of Nu Skin Enterprises, Inc. (“the Board”), are writing to provide you with additional information regarding our proposal to re-elect Zheqing (Simon) Shen to our Board at the upcoming 2020 Annual Meeting of Stockholders on June 3, 2020.
We are aware of our investors’ voting policies regarding director attendance. In our 2020 proxy statement, we disclosed that Mr. Shen attended 73% of the aggregate Board and Nominating and Corporate Governance Committee meetings during 2019. Mr. Shen attended all regularly-scheduled meetings—most of the time in person, which involves a special trip from his home in Hong Kong to our corporate headquarters in Utah. We appreciate his efforts and sacrifice in this regard.
The Board and the Nominating and Corporate Governance Committee held an aggregate of 11 meetings during 2019 (counting Committee meetings during the time Mr. Shen served on the Committee), and Mr. Shen was unable to attend three of those meetings. The three meetings he missed were specially-scheduled meetings that had not been on the planned meeting calendar set out for 2019 Board service. In all three cases, time zone differences and prior commitments prevented him from attending.
In addition, 2019 was the first time during his tenure on our Board that Mr. Shen’s attendance was below 75%. He actively participates in events and discussions that are not official meetings; he is always available to be a sounding board for our management team regarding Mainland China issues, and he participates in informal Board-update calls. Taking into account these informal Board-update calls together with the formal meetings held in 2019, his aggregate 2019 attendance was 75%, as he participated in four out of five calls in 2019.
We consider Mr. Shen to be a strong and active member of our Board. Our proxy statement discusses the strengths that he brings to the Board, including a strong network in Mainland China and valuable local knowledge of Mainland China. His background and experience are extremely valuable because Mainland China is a key market for us; it is our largest market by revenue, representing 30% of our 2019 revenue. Our Greater China region, consisting of our Mainland China and Hong Kong/Taiwan segments, represents 37% of our 2019 revenue.
Having a Board member in a different country is always a challenge, and conflicts in schedules inevitably arise from time to time due to the different time zones. However, Mr. Shen plays an important role on our Board. From our perspective, we have never considered Mr. Shen to be an absentee member of the Board. Nevertheless, Mr. Shen has informed us that he plans to have at least 75% attendance going forward.
We agree that meeting attendance is important. Mr. Shen was just two percentage points away from satisfying our investors’ voting-policy threshold. In this case, we believe such policies do not take into account Mr. Shen’s true involvement and value to our Board.
On behalf of the Board of Directors of Nu Skin Enterprises, Inc., with respect to our upcoming Annual Meeting to be held on June 3, 2020, we request your vote:
“FOR” the Election of Director Zheqing (Simon) Shen, Independent Director and member of the Nominating and Corporate Governance Committee.
Sincerely,
The Board of Directors of Nu Skin Enterprises, Inc.

SOLICITATION OF PROXIES
Expenses for the solicitation of proxies for our Annual Meeting include reimbursements paid to brokerage firms and others for their expenses incurred in forwarding solicitation material to beneficial owners of our stock. Our regular employees may further solicit proxies by telephone, by mail, in person or by electronic communication and will not receive additional compensation for such solicitation. In addition, we have retained Okapi Partners LLC to assist in the solicitation of proxies for a fee estimated to be approximately $12,500, plus reasonable out-of-pocket expenses.